Amlodipine Besylate and Benazepril Hydrochloride NDC 69238-2684

NDC codes

FDA NDC Directory

Product NDC (as listed)69238-2684Labeler and product segments. Claims need a package NDC.

Product NDC at billing width69238-2684Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
69238-2684-1	69238268401	100 CAPSULE in 1 BOTTLE (69238-2684-1)Marketed from Apr 14, 2026

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Amlodipine Besylate and Benazepril Hydrochloride
Generic name (nonproprietary): amlodipine besylate and benazepril hydrochloride
Active ingredients: Amlodipine besylate — 2.5 mg/1Benazepril hydrochloride — 10 mg/1
Dosage form: Capsule
Route: Oral
Labeler: Amneal Pharmaceuticals NY LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 077215
Marketing start: Apr 14, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Angiotensin-converting Enzyme Inhibitors (Mechanism)Calcium Channel Antagonists (Mechanism)Cytochrome P450 3A Inhibitors (Mechanism)Decreased Blood Pressure (Physiologic effect)Dihydropyridines (Chemical structure)
Identifiers: Product ID 69238-2684_9c78bd64-01e2-4597-838a-947cdaba7ba2SPL ID 9c78bd64-01e2-4597-838a-947cdaba7ba2SPL set ID 856a8cdc-57cc-4355-966d-986bbc5fa6e6RxCUI 898342, 898350, 898353, 898356UNII 864V2Q084H, N1SN99T69T
Pharmacologic class: Angiotensin Converting Enzyme Inhibitor; Calcium Channel Blocker; Dihydropyridine Calcium Channel Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N469238268401 followed by a unit qualifier and the quantity

Package 69238-2684-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Mar 31, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

Amlodipine and benazepril hydrochloride capsules are a combination capsule of amlodipine, a dihydropyridine calcium channel blocker (DHP CCB) and benazepril, an angiotensin-converting enzyme (ACE) inhibitor. Amlodipine and benazepril hydrochloride capsules are indicated for the treatment of hypertension in patients not adequately controlled on monotherapy with either agent. (1) 1.1 Hypertension Amlodipine and benazepril hydrochloride capsules are indicated for the treatment of hypertension in patients not adequately controlled on monotherapy with either agent.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 077215

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 077215
Product	Strength	Form · route	Labeler	Product NDC
Amlodipine Besylate and Benazepril Hydrochloride	Amlodipine besylate 10 mg/1; Benazepril hydrochloride 20 mg/1	CapsuleOral	Amneal Pharmaceuticals NY LLC	69238-2687
Amlodipine Besylate and Benazepril Hydrochloride	Amlodipine besylate 5 mg/1; Benazepril hydrochloride 10 mg/1	CapsuleOral	Amneal Pharmaceuticals NY LLC	69238-2685
Amlodipine Besylate and Benazepril Hydrochloride	Amlodipine besylate 5 mg/1; Benazepril hydrochloride 20 mg/1	CapsuleOral	Amneal Pharmaceuticals NY LLC	69238-2686